# Janux Therapeutics, Inc.: Form 8-K, filed Aug 7, 2024

- Company: [Janux Therapeutics, Inc.](/companies/janx.md) (CIK 1817713)
- Form: 8-K
- Filed: 2024-08-07
- Accepted by EDGAR: Aug 7, 2024, 16:20 ET
- Period: 2024-08-07
- Accession: 0000950170-24-092830
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1817713/000095017024092830/janx-20240807.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1817713/000095017024092830/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1817713/000095017024092830/janx-20240807.htm

Filed Aug 7, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-092830. Last ingested by Listed: Nov 5, 2026, 18:20 ET. No prices; not investment advice.